IFP Advisors’s ProShares UltraPro Short NASDAQ Biotechnology ZBIO Stock Holding History

IFP Advisors’s Portfolio ZBIO Stock Details ZBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-500	Closed	-$21K	–	4214
2016 Q3	$21K	Buy	+500	New	+$23.1K	﹤0.01%	2379

Other funds holding ZBIO

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

IFP Advisors's ZBIO Position: Q4 2016 in Review

IFP Advisors sold out of ProShares UltraPro Short NASDAQ Biotechnology (ZBIO) in Q4 2016, closing a stake of 500 shares — an estimated $21K sold.

IFP Advisors first reported a position in ZBIO in Q3 2016 and held it in 1 quarter. The position peaked at $21K in Q3 2016. 3 funds tracked by Wall St. Rank hold ZBIO as of Q4 2016.

IFP Advisors reported no remaining ProShares UltraPro Short NASDAQ Biotechnology position as of Q4 2016 after selling out during the quarter.
IFP Advisors sold 500 ProShares UltraPro Short NASDAQ Biotechnology shares in Q4 2016, an estimated $21K.
IFP Advisors first reported a position in ProShares UltraPro Short NASDAQ Biotechnology in Q3 2016 and held it in 1 quarter.
IFP Advisors's ProShares UltraPro Short NASDAQ Biotechnology position peaked at $21K in Q3 2016.
3 funds tracked by Wall St. Rank held ProShares UltraPro Short NASDAQ Biotechnology as of Q4 2016.

Based on IFP Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.